Israel-Cannabis has partnered with Polish biologist and entrepreneur, Rafał Ślusarczyk, to form Cannabinit, a new company that utilizes revolutionary technology to produce high quality plant cells in vitro. This process eliminates the need to grow a whole plant or the need for a growing facility at all.
Just days ago, Cannabinit came in first place in the CannX Medical Cannabis Conference start-up competition which took place in Tel Aviv.
Ślusarczyk, a former manager at the academic business incubator and biologist from the West Pomeranian University of Technology in Poland, devised the novel technique. Compared to greenhouse growing, the process is highly efficient, avoids risk of plant diseases or genetic variations/mutations, and results in controlled, standardized plant extract.
The technology has been successfully used on lavender plants and now Ślusarczyk is working to transfer the technology to the medical cannabis world and bring it to market with the help of iCAN’s expertise, global network and reputation.
Cannabinit will join iCAN’s portfolio of successfully incubated projects including CMTREX and Yom Chai.
Saul Kaye, CEO and Founder of iCAN said, “I will be mentoring Rafał Ślusarczyk through the EU Science exchange program, Erasmus for Young Entrepreneurs and am excited about the great potential of his discovery. In contrast to the process of growing cannabis in a greenhouse, we believe that this breakthrough process will lower costs of maintenance and is significantly more efficient. Furthermore, there is no risk of plant diseases and there will be no difficulty in the standardization of the final product, a serious market concern. Controlling the content of the cells in the cannabis plant is a game changer for the developing medical cannabis market. I am thrilled that Cannabinit will join iCAN’s incubator portfolio and certain that we will successfully launch this revolutionary technology.”
Our mission is to bring relief to patients by providing pharmaceuticals based on active substances from medical hemp to the Polish pharmaceutical market and beyond. We will participate in research and development projects aimed at creating innovative medicines, conduct educational activities and promote cannabis treatment. Click on the Cannabinitlink for more information.
iCAN is building the global cannabis ecosystem. iCAN identifies and accelerates innovative medical cannabis technologies and creates synergy and cooperation across the industry. iCAN uses its global network and reach to position Israel as the leading medical cannabis tech hub.
This project is seeking seed funding and we invite strategic investors to reach out to firstname.lastname@example.org
For media inquiries contact Laura Kam at email@example.com +972-54-806-8613.